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Background
Cardiac MRI has been shown to be the gold standard for
noninvasive assessment of myocardial fibrosis. The extent
of fibrosis has been associated with worse outcomes in
patients undergoing CABG surgery. The presence of
fibrosis and associated clinical features of patients with
chronic mitral regurgitation undergoing mitral valve
repair have not been described. The objective of this
study is to examine prognostic value of preoperative
myocardial fibrosis assessment by cardiac MRI in patients
with chronic mitral regurgitation undergoing mitral valve
repair.
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Age, years (SD) 61 (13) 59 (11) 65 (15) 0.112
Male sex, No. (%) 33 (69) 18 (62.1) 15 (78.9) 0.217
BMI, kg/m2 (range) 28.4 (19.0-56.1) 27.0 (19.0-56.1) 29.4 (19.5-53.5) 0.348
Functional mitral regurgitation, No. (%) 13 (27.1) 5 (17.2) 8 (42.1) 0.06
History of diabetes mellitus, No. (%) 7 (14.6) 3 (10.3) 4 (21.1) 0.31
History of dyslipidemia, No. (%) 23 (47.9) 11 (37.9) 12 (63.2) 0.09
History of hypertension, No. (%) 30 (62.5) 16 (55.2) 14 (73.7) 0.20
Hemoglobin level on admission, g/dL (range) 13 (7-16) 13.0 (8.0-15.0) 13.0 (7.0-16.0) 0.574
Statins, No. (%) 14 (29.2) 6 (20.7) 8 (42.1) 0.110
ACEI or ARB, No. (%) 19 (39.6) 8 (27.6) 11 (57.9) 0.036
b blockers, No. (%) 25 (52.1) 12 (41.4) 13 (68.4) 0.067
Aspirin, No. (%) 22 (45.8) 13 (44.8) 9 (47.4) 0.863
Cardiac MRI LVEF, % (SD) 63.04 (11.86) 63.31 (12.34) 62.63 (11.40) 0.85
Cardiac MRI RVEF, % (SD) 52.00 (10.33) 52.97 (10.62) 48.84 (9.60) 0.18
Cardiac MRI LVEDV, mL (SD) 200.00(61.34) 199.42 (57.56) 198.34 (68.33) 0.95
Cardiac MRI LVESV, mL (SD) 68.50 (41.03) 75.63 (40.25) 76.50 (43.31) 0.94
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Methods
This is a prospectively enrolled consecutive series of 48
subjects with chronic mitral regurgitation who underwent
cardiac MRI followed by mitral valve repair using the non-
resectional dynamic technique from August 2008 - April
2013. Pre-operative fibrosis burden, other cardiac MRI
and clinical variables were collected. Differences among
variables between subjects with and without fibrosis were
statistically calculated.
Results
The cohort had a mean (SD) age of 61(13) years and
included 33 men (69%). Median postoperative follow up
interval was 53.5 days (Interquartile range 10 and 442
days). Mean (SD) interval between cardiac MRI and mitral
valve repair was 19.58 (18.37) days. Fibrosis was present in
19 subjects (39.6%) with a median fibrosis burden of 4% of
the left ventricle. Within the fibrosis group, 9 (47.4%) had a
non-coronary artery disease fibrosis pattern. Comparison of
selected baseline clinical and cardiac MRI variables is
shown in the Table 1. Postoperative clinical outcomes are
shown in the Table 2. In multivariable analysis, presence of
preoperative fibrosis is an independent predictor for post-
operative cardiac pacing (OR 7.652; 95%CI 1.636, 35.783,
p0.010), postoperative significant arrhythmia (OR 4.403;
95%CI 0.997, 19.443, p0.050) and a composite of ICU read-
mission/postoperative significant arrhythmia/postoperative
cardiac pacing (OR 5.057; 95%CI 1.130, 22.622, p0.034).
Conclusions
Presence of preoperative myocardial fibrosis derived from
cardiac MRI is associated with worse postoperative out-
comes in patients with chronic mitral regurgitation under-
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Table 2 Postoperative clinical outcomes categorized by presence of myocardial fibrosis







Significant arrhythmia*, No. (%) 24 (50.0) 10 (34.5) 14 (73.7) 0.008
Cardiac pacing, No. (%) 20 (41.7) 7 (24.1) 13 (68.4) 0.002
ICU readmission or significant arrhythmia or cardiac pacing 25 (52.1) 4 (17.4) 15 (60.0) 0.003
* Atrial fibrillation, sinus bradycardia requiring cardiac pacing, AV blocks requiring cardiac pacing
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